End Price Gouging for Medications Act
Summary
End Price Gouging for Medications Act This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including drug prices in listed countries. Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2021
Committee Review
Floor Vote
President
Introduced Apr 22, 2021
Last action Jul 14, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
6
Key actions
0
Committee
5
Jul 14, 2021
Committee
Referred to the Subcommittee on Health.
lower
Jun 16, 2021
Committee
Referred to the Subcommittee for Indigenous Peoples of the United States.
lower
Apr 23, 2021
Committee
Referred to the Subcommittee on Health.
lower
Apr 22, 2021
Committee
Referred to the Subcommittee on Health.
lower
Apr 22, 2021
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, Veterans' Affairs, Oversight and Reform, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Apr 22, 2021
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 2829
Scope: US
Hi! I can help you understand HR 2829. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline